Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 12163
TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683329(US20240217922, Example 6 | US20240217922, Example ...)
Affinity DataIC50: 60nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683329(US20240217922, Example 6 | US20240217922, Example ...)
Affinity DataIC50: 60nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683325(US20240217922, Example 1 | US20240217922, Example ...)
Affinity DataIC50: 90nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683341(US20240217922, Example 18)
Affinity DataIC50: 90nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683340(US20240217922, Example 17)
Affinity DataIC50: 100nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683335(US20240217922, Example 13)
Affinity DataIC50: 120nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683327(US20240217922, Example 4)
Affinity DataIC50: 140nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683334(US20240217922, Example 12)
Affinity DataIC50: 150nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683337(US20240217922, Example 14)
Affinity DataIC50: 240nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683328(US20240217922, Example 5)
Affinity DataIC50: 270nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683339(US20240217922, Example 16)
Affinity DataIC50: 290nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683338(US20240217922, Example 15)
Affinity DataIC50: 310nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683331(US20240217922, Example 9)
Affinity DataIC50: 620nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683325(US20240217922, Example 1 | US20240217922, Example ...)
Affinity DataIC50: 1.67E+3nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683332(US20240217922, Example 10)
Affinity DataIC50: 2.03E+3nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent

TargetSortilin(Human)
Insusense

US Patent
LigandPNGBDBM683330(US20240217922, Example 8)
Affinity DataIC50: 2.17E+3nMAssay Description:Compound affinity was determined by measuring the displacement of[3H]-neurotensin or [125I]-neurotensin binding to hSortilin in SPA format. Total vol...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/11/2024
Entry Details
Go to US Patent